Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Early US Experience Using the Symani for Robotic-Assisted Microvascular Surgery.

Created on 17 Nov 2026

Authors

Arturo J Rios-Diaz, Sarah N Bishop, Berk B Ozmen, Stephen J Kovach, Ines Lin, Diwakar Phuyal, Jessica F Rose, Risal S Djohan, Graham S Schwarz, L Scott Levin

Published in

Microsurgery. Volume 46. Issue 8.

Abstract

Robotic-assisted microsurgery provides motion scaling, tremor filtration, and enhanced visualization, offering potential advantages for complex microsurgical tasks. Following Food and Drug Administration authorization, the Symani Surgical System was introduced into clinical practice in the United States in April 2024. This study presents the first multi-institutional US experience with Symani, evaluating feasibility, reconstructive outcomes, and technical challenges during its inaugural year of use in the United States.
All robotic-assisted procedures performed between April 2024 and April 2025 at two tertiary academic centers were retrospectively reviewed. Demographics, clinical indications, flap type, and anastomotic details were extracted. Primary outcomes were anastomotic patency and flap loss. Secondary outcomes included overall surgical complications and conversion to conventional microsurgery.
Twenty-seven patients underwent robotic-assisted microsurgical procedures. Median age was 51 [IQR 39-63] years; 55.6% were female, and 74.1% identified as White. Indications included oncologic reconstruction (48.1%), trauma (18.5%), degenerative bony disease (14.8%), infection (11.1%), peripheral vascular disease (3.7%), and morphea (3.7%). A wide variety of flaps were performed, most commonly deep inferior epigastric perforator (DIEP) (44.4%), free vascularized fibular grafts (18.5%), and scapular flaps (14.8%). Robotic assistance was employed for 27 arterial anastomoses (84.4%), three venous anastomoses (9.4%), and two nerve coaptations (6.3%). Anastomotic configuration was predominantly end-to-end (71.9%). No flap loss occurred. One patient (3.7%) required re-exploration for pedicle kinking. Two conversions to conventional non-robotic microsurgery were required (7.4%).
Early US multi-institutional experience demonstrates the Symani system is feasible and safe across diverse reconstructive procedures, enabling reliable microvascular anastomoses and nerve coaptations with minimal complications and no flap loss.

PMID:
43040987
Bibliographic data and abstract were imported from PubMed on 17 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 11
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement